GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (FRA:MFY) » Definitions » E10

Mochida Pharmaceutical Co (FRA:MFY) E10 : €1.35 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Mochida Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.287. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.35 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Mochida Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mochida Pharmaceutical Co was 2.70% per year. The lowest was -3.50% per year. And the median was 1.00% per year.

As of today (2024-06-08), Mochida Pharmaceutical Co's current stock price is €17.60. Mochida Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was €1.35. Mochida Pharmaceutical Co's Shiller PE Ratio of today is 13.04.

During the past 13 years, the highest Shiller PE Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.81. And the median was 16.91.


Mochida Pharmaceutical Co E10 Historical Data

The historical data trend for Mochida Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co E10 Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.69 1.61 1.64 1.49 -

Mochida Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.49 1.38 1.37 1.35 -

Competitive Comparison of Mochida Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.



Mochida Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.287/106.8000*106.8000
=0.287

Current CPI (Dec. 2023) = 106.8000.

Mochida Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201403 0.244 95.700 0.272
201406 0.345 98.000 0.376
201409 0.212 98.500 0.230
201412 0.578 97.900 0.631
201503 0.203 97.900 0.221
201506 0.580 98.400 0.630
201509 0.302 98.500 0.327
201512 0.681 98.100 0.741
201603 -0.050 97.900 -0.055
201606 0.697 98.100 0.759
201609 0.504 98.000 0.549
201612 0.871 98.400 0.945
201703 -0.265 98.100 -0.289
201706 0.873 98.500 0.947
201709 0.306 98.800 0.331
201712 0.631 99.400 0.678
201803 -0.048 99.200 -0.052
201806 1.145 99.200 1.233
201809 0.210 99.900 0.225
201812 0.575 99.700 0.616
201903 -0.287 99.700 -0.307
201906 0.690 99.800 0.738
201909 0.277 100.100 0.296
201912 0.377 100.500 0.401
202003 -0.386 100.300 -0.411
202006 0.717 99.900 0.767
202009 0.424 99.900 0.453
202012 0.614 99.300 0.660
202103 0.036 99.900 0.038
202106 0.523 99.500 0.561
202109 0.456 100.100 0.487
202112 1.071 100.100 1.143
202203 0.079 101.100 0.083
202206 0.593 101.800 0.622
202209 0.145 103.100 0.150
202212 0.783 104.100 0.803
202303 -0.274 104.400 -0.280
202306 0.302 105.200 0.307
202309 0.204 106.200 0.205
202312 0.287 106.800 0.287

Add all the adjusted EPS together and divide 10 will get our e10.


Mochida Pharmaceutical Co  (FRA:MFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17.60/1.35
=13.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.81. And the median was 16.91.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mochida Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Mochida Pharmaceutical Co (FRA:MFY) Business Description

Traded in Other Exchanges
Address
1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (FRA:MFY) Headlines

No Headlines